
==== Front
BMJ OpenBMJ OpenbmjopenbmjopenBMJ Open2044-6055BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR bmjopen-2013-003424corr110.1136/bmjopen-2013-003424corr1CorrectionCorrection 2014 27 3 2014 4 3 e003424corr1Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions2014
==== Body
Ehrenstein V, Hernandez RK, Ulrichsen SP, et al. Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010. BMJ Open 2013;3:e003424. In the section ‘Ethics approval’ the record number with the Danish Data Protection Agency is incorrect. The sentence should read: ‘Ethics approval This study was approved by the Danish Data Protection Agency (record number 2004-41-4693) and by the Independent Scientific Advisory Committee of the GPRD.’
